ZURICH/BERLIN, Dec 22 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Wednesday:
JULIUS BAER BAER.S
Evie Kostakis to succeed Dieter Enkelmann as chief financial
officer; Enkelmann will step down effective 1 July 2022 BAER.S
SIKA SIKA.S
Proposes increasing conditional capital by 3.2 mln shares
SIKA.S
NOVARTIS NOVN.S
Generics arm Sandoz submits marketing authorization
application for proposed biosimilar trastuzumab, the breast
cancer drug marketed by Roche ROG.S as Herceptin, to EMA
NOVN.S
COMPANY STATEMENTS
* SFS Group SFSN.S buys German tool maker Hoffmann SE
SFSN.S
* Cicor Technologies Ltd CICN.S : announces details of
planned mandatory convertible bond issue; amount of up to around
CHF 60 million, guaranteed by One Equity Partners CICN.S
* Valora Holding AG VALN.S : roll-out of 300,000 kiosk
machines across Switzerland by end of 2022 VALN.S
* Landis+Gyr LANDI.S appoints Sean Cromie as new EVP
Americas
ANALYST VIEWS
ROCHE HOLDING AG ROG.S : CITIGROUP RESUMES COVERAGE WITH
BUY RATING; TARGET PRICE CHF 422
ECONOMY
No major Swiss economic data scheduled
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))